{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:24:41Z","timestamp":1785587081331,"version":"3.56.0"},"reference-count":74,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Serving as central signalling organelles and hubs of metabolism, mitochondria are essential for cellular homeostasis. Mitochondrial disease can arise from mutations to nuclear or mitochondrial DNA, which result in disruptions to normal mitochondrial function. This generates a suite of rare disorders which are multi-system and often fatal. Variable tissue distribution of mitochondria, alongside a high degree of heterogeneity in associated phenotype, has resulted in an inadequate understanding and characterisation of mitochondrial disease. Addressing this issue is therefore crucial for better clinical management and patient outcomes. Cholesterol dyshomeostasis is a potential pathological hallmark of numerous mitochondrial diseases. Cholesterol is an essential lipid and bioactive compound involved in numerous mitochondrial and cellular processes. A growing number of studies have reported perturbations to cholesterol biosynthesis, cholesterol import, and cholesterol ratios in cell and animal models and individuals with mitochondrial disease, suggesting it could be a unifying feature of these disparate and variable disorders. This review summarises the current experimental evidence for the role of cholesterol dyshomeostasis in mitochondrial disease. It will further discuss reports of statin intolerance, generally attributed to off-target action on mitochondrial structures, in the context of this evidence. Ultimately, the necessity of further integrative clinical and experimental studies exploring the potential of cholesterol dyshomeostasis as a pathological hallmark of mitochondrial disease will be highlighted.<\/jats:p>","DOI":"10.3390\/ijms27104353","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:26:37Z","timestamp":1778689597000},"page":"4353","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cholesterol in Mitochondrial Diseases\u2014Friend or Foe?"],"prefix":"10.3390","volume":"27","author":[{"given":"Mila","family":"Taylor","sequence":"first","affiliation":[{"name":"Department of Biosciences, Durham University, Durham DH1 3LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Halicki","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Durham University, Durham DH1 3LE, UK"},{"name":"Medical Research Council Prion Unit at UCL, Institute of Prion Diseases, University College London, London W1W 7FF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-0379","authenticated-orcid":false,"given":"Paul","family":"Chazot","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Durham University, Durham DH1 3LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","article-title":"Mitochondrial diseases: From molecular mechanisms to therapeutic advances","volume":"10","author":"Wen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/brain\/awae018","article-title":"Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation","volume":"147","author":"Sandoval","year":"2024","journal-title":"Brain"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00109-023-02358-9","article-title":"Distinctive metabolic remodeling in TYMP deficiency beyond mitochondrial dysfunction","volume":"101","author":"Du","year":"2023","journal-title":"J. Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e202302423","DOI":"10.26508\/lsa.202302423","article-title":"Mitochondrial translation failure represses cholesterol gene expression via Pyk2-Gsk3beta-Srebp2 axis","volume":"7","author":"Toshima","year":"2024","journal-title":"Life Sci. Alliance"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"166062","DOI":"10.1016\/j.bbadis.2020.166062","article-title":"Stimulation of cholesterol biosynthesis in mitochondrial complex I-deficiency lowers reductive stress and improves motor function and survival in mice","volume":"1867","author":"Schirris","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nmd.2024.06.004","article-title":"Statins in hereditary myopathies: To give or not to give","volume":"41","author":"Argov","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism","volume":"8","author":"Golomb","year":"2008","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10557-019-06904-x","article-title":"State of the Art Comprehensive Review of Individual Statins, Their Differences, Pharmacology, and Clinical Implications","volume":"33","author":"Azemawah","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-019-2036-9","article-title":"Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells","volume":"10","author":"Pek","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e13206","DOI":"10.1111\/acel.13206","article-title":"Mitochondrial DNA mutation exacerbates female reproductive aging via impairment of the NADH\/NAD(+) redox","volume":"19","author":"Yang","year":"2020","journal-title":"Aging Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1096\/fj.10-165340","article-title":"Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts","volume":"25","author":"Cotan","year":"2011","journal-title":"FASEB J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"165726","DOI":"10.1016\/j.bbadis.2020.165726","article-title":"Parkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome","volume":"1866","author":"Jackson","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1023\/A:1012415810881","article-title":"Phenotype variability in 130 adult patients with respiratory chain disorders","volume":"24","author":"Finsterer","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrm.2017.16","article-title":"The mystery of membrane organization: Composition, regulation and roles of lipid rafts","volume":"18","author":"Sezgin","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","article-title":"Mevalonate pathway: A review of clinical and therapeutical implications","volume":"40","author":"Buhaescu","year":"2007","journal-title":"Clin. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: From mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbalip.2009.03.001","article-title":"Cholesterol transport in steroid biosynthesis: Role of protein-protein interactions and implications in disease states","volume":"1791","author":"Rone","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1038\/srep15292","article-title":"Human Mitochondrial DNA-Protein Complexes Attach to a Cholesterol-Rich Membrane Structure","volume":"5","author":"Gerhold","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102643","DOI":"10.1016\/j.redox.2023.102643","article-title":"Mitochondrial cholesterol: Metabolism and impact on redox biology and disease","volume":"61","author":"Goicoechea","year":"2023","journal-title":"Redox Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"101652","DOI":"10.1016\/j.jbc.2022.101652","article-title":"Mitochondrial respiratory chain dysfunction alters ER sterol sensing and mevalonate pathway activity","volume":"298","author":"Wall","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1083\/jcb.200609158","article-title":"The AAA+ protein ATAD3 has displacement loop binding properties and is involved in mitochondrial nucleoid organization","volume":"176","author":"He","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chen, L., Li, Y., Zambidis, A., and Papadopoulos, V. (2023). ATAD3A: A Key Regulator of Mitochondria-Associated Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512511"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8060949","DOI":"10.1155\/2017\/8060949","article-title":"Mitochondrial Nucleoid: Shield and Switch of the Mitochondrial Genome","volume":"2017","author":"Lee","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/en.2014-1503","article-title":"Mitochondria-associated membrane formation in hormone-stimulated Leydig cell steroidogenesis: Role of ATAD3","volume":"156","author":"Issop","year":"2015","journal-title":"Endocrinology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101041","DOI":"10.1016\/j.jbior.2024.101041","article-title":"Advancements in unravelling the fundamental function of the ATAD3 protein in multicellular organisms","volume":"93","author":"Goel","year":"2024","journal-title":"Adv. Biol. Regul."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajhg.2020.01.007","article-title":"Recurrent De Novo NAHR Reciprocal Duplications in the ATAD3 Gene Cluster Cause a Neurogenetic Trait with Perturbed Cholesterol and Mitochondrial Metabolism","volume":"106","author":"Gunning","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2020.09.002","article-title":"Mitochondrial dysfunction caused by novel ATAD3A mutations","volume":"131","author":"Dorison","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/brain\/awx094","article-title":"ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolism","volume":"140","author":"Desai","year":"2017","journal-title":"Brain"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"jcs217075","DOI":"10.1242\/jcs.217075","article-title":"ATAD3 controls mitochondrial cristae structure in mouse muscle, influencing mtDNA replication and cholesterol levels","volume":"131","author":"Peralta","year":"2018","journal-title":"J. Cell Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1093\/brain\/awae402","article-title":"Elevated cholesterol is a common phenotype for dominant and recessive ATAD3-associated disorders","volume":"148","author":"Kiesel","year":"2025","journal-title":"Brain"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.freeradbiomed.2025.01.009","article-title":"Coenzyme Q(10) deficiency disrupts lipid metabolism by altering cholesterol homeostasis in neurons","volume":"229","author":"Pesini","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Menacho, C., Okawa, S., \u00c1lvarez-Merz, I., Wittich, A., Mu\u00f1oz-Oreja, M., Lisowski, P., Pentimalli, T.M., Rybak-Wolf, A., Inak, G., and Zakin, S. (2024). Deep learning-driven neuromorphogenesis screenings identify repurposable drugs for mitochondrial disease. Biorxiv, preprint.","DOI":"10.1101\/2024.07.08.602501"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"141055","DOI":"10.1016\/j.bbapap.2024.141055","article-title":"Ndufs4 knockout mice with isolated complex I deficiency engage a futile adaptive brain response","volume":"1873","author":"Doornbos","year":"2025","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"ref_37","first-page":"123231","article-title":"Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder","volume":"4","author":"Ruiz","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.celrep.2015.09.054","article-title":"A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome","volume":"13","author":"Strittmatter","year":"2015","journal-title":"Cell Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1093\/hmg\/ddx202","article-title":"Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion","volume":"26","author":"Cuillerier","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bakare, A.B., Lesnefsky, E.J., and Iyer, S. (2021). Leigh Syndrome: A Tale of Two Genomes. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.693734"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s13311-022-01216-9","article-title":"Bezafibrate Rescues Mitochondrial Encephalopathy in Mice via Induction of Daily Torpor and Hypometabolic State","volume":"19","author":"Lyu","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"165727","DOI":"10.1016\/j.bbadis.2020.165727","article-title":"Effects of clofibrate and KH176 on life span and motor function in mitochondrial complex I-deficient mice","volume":"1866","author":"Frambach","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/hmg\/ddr482","article-title":"Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice","volume":"21","author":"Yatsuga","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/tgh-20-125","article-title":"Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease","volume":"6","author":"Prasun","year":"2021","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.3390\/ijms15058713","article-title":"Role of mitochondria in nonalcoholic fatty liver disease","volume":"15","author":"Nassir","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e0434","DOI":"10.1097\/HC9.0000000000000434","article-title":"An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD","volume":"8","author":"Zhang","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/hc0702.103977","article-title":"Cigarette Smoke Exposure and Hypercholesterolemia Increase Mitochondrial Damage in Cardiovascular Tissues","volume":"105","author":"Young","year":"2002","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Braczko, A., Kutryb-Zajac, B., Jedrzejewska, A., Krol, O., Mierzejewska, P., Zabielska-Kaczorowska, M., Slominska, E.M., and Smolenski, R.T. (2022). Cardiac Mitochondria Dysfunction in Dyslipidemic Mice. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911488"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"111478","DOI":"10.1016\/j.jclinepi.2024.111478","article-title":"The evidence base of the 10 most prescribed drugs in England, France, and the United States: A scoping review","volume":"174","author":"Fournier","year":"2024","journal-title":"J. Clin. Epidemiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4068\/cmj.2013.49.1.1","article-title":"Role of Statins in Coronary Artery Disease","volume":"49","author":"Lim","year":"2013","journal-title":"Chonnam Med. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00003495-200161020-00005","article-title":"Safety Profiles for the HMG-CoA Reductase Inhibitors: Treatment and Trust","volume":"61","author":"Davidson","year":"2001","journal-title":"Drugs"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: Mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"J. Cell. Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Hidalgo-Guti\u00e9rrez, A., Gonz\u00e1lez-Garc\u00eda, P., D\u00edaz-Casado, M.E., Barriocanal-Casado, E., L\u00f3pez-Herrador, S., Quinzii, C.M., and L\u00f3pez, L.C. (2021). Metabolic Targets of Coenzyme Q10 in Mitochondria. Antioxidants, 10.","DOI":"10.3390\/antiox10040520"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-Associated Myopathy with Normal Creatine Kinase Levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_58","first-page":"1380","article-title":"Patient care standards for primary mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society","volume":"19","author":"Parikh","year":"2017","journal-title":"Genet. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000101287","article-title":"Statins Provoking MELAS Syndrome","volume":"57","author":"Thomas","year":"2007","journal-title":"Eur. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0002-9343(93)90129-D","article-title":"Simvastatin-induced rhabdomyolysis followed by a melas syndrome","volume":"94","author":"Chariot","year":"1993","journal-title":"Am. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pediatrneurol.2008.09.002","article-title":"Myotoxicity of Lipid-Lowering Agents in a Teenager with MELAS Mutation","volume":"39","author":"Tay","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.jacl.2025.04.056","article-title":"Hypercholesterolemia management in a patient with mitochondrial encephalomyopathy lactic acidosis, and stroke-like episodes","volume":"19","author":"Anderson","year":"2025","journal-title":"J. Clin. Lipidol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jacl.2020.07.007","article-title":"Successful treatment of a patient with mitochondrial myopathy with alirocumab","volume":"14","author":"Cicero","year":"2020","journal-title":"J. Clin. Lipidol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.SMJ.0000061501.81880.83","article-title":"Statins Unmasking a Mitochondrial Myopathy: A Case Report and Proposed Mechanism of Disease","volume":"96","author":"Diaczok","year":"2003","journal-title":"S. Med. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1600-0463.2005.apm_270.x","article-title":"Statin-associated myopathy with normal creatine kinase levels: Case report from a Norwegian family","volume":"113","author":"Henriksen","year":"2005","journal-title":"APMIS"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinte.166.14.1519","article-title":"Presymptomatic Neuromuscular Disorders Disclosed Following Statin Treatment","volume":"166","author":"Tsivgoulis","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000530221","article-title":"Concentric Reversible Visual Field Loss, Nyctalopia, and Dyschromatopsia with Ezetimibe Therapy","volume":"28","author":"Xu","year":"2023","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_68","unstructured":"Sizar, O., Nassereddin, A., and Talati, R. (2023, August 28). Ezetimibe, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532879\/."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.amjmed.2005.06.051","article-title":"Monotherapy with Ezetimibe Causing Myopathy","volume":"119","author":"Havranek","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1755-5922.12236","article-title":"Ezetimibe: Use, costs, and adverse events in Australia","volume":"35","author":"Hollingworth","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"100777","DOI":"10.1016\/j.ajpc.2024.100777","article-title":"Monotherapy Ezetimibe-Induced Rhabdomyolysis","volume":"19","author":"Baviriseaty","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/qjmed\/hci074","article-title":"Worsening myopathy associated with ezetimibe in a patient with McArdle disease","volume":"98","year":"2005","journal-title":"Qjm Int. J. Med."},{"key":"ref_73","unstructured":"Lam, J.R., Anastasopoulou, C., Khattak, Z.E., and Ashraf, M. (2025, January 22). McArdle Disease (Glycogen Storage Disease Type 5), StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560785\/."},{"key":"ref_74","first-page":"141","article-title":"Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"22","author":"Simard","year":"2006","journal-title":"Can. J. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4353\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:33:26Z","timestamp":1779280406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":74,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104353"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104353","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}